Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on August 2nd, 2023%
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds
By Alan, on August 1st, 2023%
The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities. . . . → Read More: Companies Partner on Fast Production of Biologics in Plants
By Alan, on July 31st, 2023%
A system using deep learning algorithms to analyze ultrasound video images is shown to detect a difficult-to diagnose type of heart failure with clips from one view of the heart. . . . → Read More: A.I. Analytics Detect Heart Failure in Single Ultrasound View
By Alan, on July 19th, 2023%
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins
By Alan, on July 3rd, 2023%
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round. . . . → Read More: Synthetic DNA Company Gains $10M in Venture Round
By Alan, on June 15th, 2023%
A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality. . . . → Read More: Synthetic Bio Company Manufactures Research Cells
By Alan, on June 12th, 2023%
A developer of fusion energy for space travel and software company for space flight systems are writing machine learning algorithms to design a hyper-fast rocket engine. . . . → Read More: Companies Partner on A.I., Fusion Energy for Space Flight
By Alan, on June 2nd, 2023%
A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans. . . . → Read More: Primate Genome A.I. Model IDs Human Disease Variants
By Alan, on May 4th, 2023%
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression. . . . → Read More: Trial Underway Testing Psychedelic Drug for Depression
By Alan, on April 25th, 2023%
A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|